{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:18Z","timestamp":1792179558509,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2003,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.fertnstert.2016.10.027","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T11:46:18Z","timestamp":1478173578000},"page":"1572-1579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome\u2014risks versus benefits"],"prefix":"10.1016","volume":"106","author":[{"given":"Anuja","family":"Dokras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.10.027_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"Noncontraceptive health benefits of combined oral contraception","volume":"11","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib2","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Zegro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. Part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrb\u00edkov\u00e1","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.2014-3196","article-title":"Approach to the patient: contraception in women with polycystic ovary syndrome","volume":"100","author":"Yildiz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib8","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"3","author":"Arowojolu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3109\/09513590.2014.943725","article-title":"Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies","volume":"30","author":"Mendoza","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","article-title":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone\u2013ethinyl estradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","volume":"94","author":"Battaglia","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.2014-0311","article-title":"A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome","volume":"20","author":"Shen","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner\u2019s guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968\u20132004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2011.10.022","article-title":"Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"97","author":"Dokras","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2016.06.012","article-title":"Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review","author":"Pagano","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib27","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/humrep\/des113","article-title":"Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study","volume":"27","author":"Cinar","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib28","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.fertnstert.2009.11.001","article-title":"Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome","volume":"94","author":"Thomson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib29","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib30","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin","volume":"93","author":"Harris-Glocker","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00401427","article-title":"Oral contraception use and the risk of type 2 diabetes in a large prospective study of women","volume":"35","author":"Rimm","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib33","first-page":"1277","article-title":"Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors","volume":"79","author":"Watanabe","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasen-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(90)90036-U","article-title":"Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins","volume":"41","author":"Ball","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2002.119179","article-title":"Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII","volume":"186","author":"Van Rooijen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","article-title":"Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response","volume":"4","author":"Van Rooijen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.clinbiochem.2009.12.013","article-title":"Effect of second and third generation oral contraceptives on C-reactive protein, lipids and apolipoproteins in young, non-obese, non-smoking apparently healthy women","volume":"43","author":"Krintus","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","article-title":"Cardiovascular disease risk in women with PCOS","volume":"78","author":"Dokras","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib42","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use. http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/MEC-5\/en\/."},{"key":"10.1016\/j.fertnstert.2016.10.027_bib43","unstructured":"US medical eligibility criteria for contraceptive use. 2016. http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/rr\/pdfs\/rr6503.pdf."},{"key":"10.1016\/j.fertnstert.2016.10.027_bib44","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib50","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib51","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib52","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jacc.2013.07.025","article-title":"The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality","volume":"62","author":"Khera","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib53","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib54","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib55","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/archinte.165.22.2644","article-title":"Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus","volume":"165","author":"Wannamethee","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib56","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib58","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.08.039","article-title":"Hormonal contraception and thrombosis","author":"Sitruk-Ware","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib60","first-page":"377","article-title":"Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003\u20132008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib61","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","article-title":"Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis","volume":"185","author":"Bird","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib62","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib63","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib64","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1467-789X.2011.00900.x","article-title":"Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management","volume":"12","author":"van de Woestijne","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib65","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","volume":"29","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib66","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinyl estradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.contraception.2012.07.005","article-title":"Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination","volume":"87","author":"Aydin","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib68","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1210\/jc.2013-1041","article-title":"Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity","volume":"98","author":"Ib\u00e1\u00f1ez","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib69","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40618-014-0103-8","article-title":"Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and\/or oral contraceptives in polycystic ovary syndrome","volume":"37","author":"Glintborg","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib70","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib71","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1210\/jc.2012-1754","article-title":"Ethinyl estradiol\u2013cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue","volume":"97","author":"D\u00edaz","year":"2012","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib72","doi-asserted-by":"crossref","first-page":"488","DOI":"10.14310\/horm.2002.1553","article-title":"The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers","volume":"13","author":"Christakou","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib73","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/cen.13112","article-title":"Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial","volume":"85","author":"Orio","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","article-title":"Adiponectin multimeric complexes and the metabolic syndrome trait cluster","volume":"55","author":"Lara-Castro","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"6 Pt 1","key":"10.1016\/j.fertnstert.2016.10.027_bib76","doi-asserted-by":"crossref","first-page":"C1645","DOI":"10.1152\/ajpcell.1998.274.6.C1645","article-title":"Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids","volume":"274","author":"Dieudonne","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2016.10.027_bib78","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03345790","article-title":"Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention","volume":"33","author":"Moran","year":"2010","journal-title":"J Endocrinol Invest"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216629503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216629503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:37:37Z","timestamp":1768221457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216629503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0015028216629503"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.027","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome\u2014risks versus benefits","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}